- Home
- ATOS vs ALTO Comparison
ATOS vs ALTO Comparison
Compare ATOS & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- ALTO
- Stock Information
- Founded
- ATOS 2009
- ALTO 2003
- Country
- ATOS United States
- ALTO United States
- Employees
- ATOS 10
- ALTO N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- ALTO Major Chemicals
- Sector
- ATOS Health Care
- ALTO Industrials
- Exchange
- ATOS Nasdaq
- ALTO Nasdaq
- Market Cap
- ATOS 114.5M
- ALTO 110.4M
- IPO Year
- ATOS 2012
- ALTO N/A
- Fundamental
- Price
- ATOS $0.96
- ALTO $1.80
- Analyst Decision
- ATOS Strong Buy
- ALTO Strong Buy
- Analyst Count
- ATOS 3
- ALTO 3
- Target Price
- ATOS $7.00
- ALTO $5.00
- AVG Volume (30 Days)
- ATOS 826.7K
- ALTO 840.0K
- Earning Date
- ATOS 11-12-2024
- ALTO 03-10-2025
- Dividend Yield
- ATOS N/A
- ALTO N/A
- EPS Growth
- ATOS N/A
- ALTO N/A
- EPS
- ATOS N/A
- ALTO N/A
- Revenue
- ATOS N/A
- ALTO $1,002,536,000.00
- Revenue This Year
- ATOS N/A
- ALTO N/A
- Revenue Next Year
- ATOS N/A
- ALTO $7.36
- P/E Ratio
- ATOS N/A
- ALTO N/A
- Revenue Growth
- ATOS N/A
- ALTO N/A
- 52 Week Low
- ATOS $0.77
- ALTO $1.18
- 52 Week High
- ATOS $2.31
- ALTO $2.40
- Technical
- Relative Strength Index (RSI)
- ATOS 39.54
- ALTO 60.03
- Support Level
- ATOS $0.81
- ALTO $1.57
- Resistance Level
- ATOS $0.94
- ALTO $1.87
- Average True Range (ATR)
- ATOS 0.05
- ALTO 0.12
- MACD
- ATOS 0.01
- ALTO 0.01
- Stochastic Oscillator
- ATOS 39.13
- ALTO 63.51
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.